| Feasibility, long‐term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients PN Harden, DS Game, B Sawitzki, JB Van der Net, J Hester, A Bushell, ... American Journal of Transplantation 21 (4), 1603-1611, 2021 | 95 | 2021 |
| Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use A Alzhrani, M Bottomley, K Wood, J Hester, F Issa Cellular immunology 357, 104214, 2020 | 17 | 2020 |
| Emerging biosensing methods to monitor lung cancer biomarkers in biological samples: a comprehensive review R Chinnappan, TA Mir, S Alsalameh, T Makhzoum, A Alzhrani, K Alnajjar, ... Cancers 15 (13), 3414, 2023 | 13 | 2023 |
| Immune monitoring for advanced cell therapy trials in transplantation: which assays and when? HL Stark, HC Wang, J Kuburic, A Alzhrani, J Hester, F Issa Frontiers in Immunology 12, 664244, 2021 | 10 | 2021 |
| Low-cost point-of-care monitoring of ALT and AST is promising for faster decision making and diagnosis of acute liver injury R Chinnappan, TA Mir, S Alsalameh, T Makhzoum, A Alzhrani, ... Diagnostics 13 (18), 2967, 2023 | 7 | 2023 |
| Using Liver Organoids as Models to Study the Pathobiology of Rare Liver Diseases DA Obeid, TA Mir, A Alzhrani, A Altuhami, T Shamma, S Ahmed, S Kazmi, ... Biomedicines 12 (2), 446, 2024 | 5 | 2024 |
| Mammalian-specific decellularized matrices derived bioink for bioengineering of liver tissue analogues: A review TA Mir, M Nakamura, S Sakai, S Iwanaga, SI Wani, A Alzhrani, K Arai, ... International Journal of Bioprinting 9 (3), 2023 | 5 | 2023 |
| Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges A Jabri, J Khan, B Taftafa, M Alsharif, A Mhannayeh, R Chinnappan, ... Bioengineering 11 (4), 346, 2024 | 3 | 2024 |
| Whole Liver Derived Acellular Extracellular Matrix for Bioengineering of Liver Constructs: An Updated Review TA Mir, A Alzhrani, M Nakamura, S Iwanaga, SI Wani, A Altuhami, ... Bioengineering 10 (10), 1126, 2023 | 3 | 2023 |
| Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal … MO Brook, C Hennessy, J Hester, S Hammad, A Alzhrani, I Rombach, ... Transplantation, 10.1097, 2024 | 2 | 2024 |
| 216.13: Spatial Protein Profiling of Leukocyte Infiltrates in Renal Biopsies After Cellular Therapy A Alzhrani, M Brook, J Hester, F Issa Transplantation 106 (9S), S57, 2022 | 1 | 2022 |
| A review of current state-of-the-art materiobiology and technological approaches for liver tissue engineering SI Wani, TA Mir, M Nakamura, T Tsuchiya, A Alzhrani, S Iwanaga, K Arai, ... Bioprinting, e00355, 2024 | | 2024 |
| An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring AI Alzhrani University of Oxford, 2021 | | 2021 |
| MASS CYTOMETRY ANALYSIS OF THE PERIPHERAL REGULATORY T CELL COMPARTMENT AFTER CELLULAR THERAPY IN RENAL TRANSPLANTATION A Alzhrani, D Ahern, J Hester, F Issa Transplantation 104 (S3), S203, 2020 | | 2020 |
| DEVELOPMENT OF A METHODOLOGY FOR THE PRODUCTION OF SPECIFIC ALLOANTIGEN-REACTIVE HUMAN T REGULATORY CELLS A Alzhrani, J Hester, F Issa Transplantation 104 (S3), S205, 2020 | | 2020 |
| DEVELOPMENT OF A METHODOLOGY FOR THE PRODUCTION OF SPECIFIC ALLOANTIGEN-REACTIVE HUMAN TREGS A Alzhrani, J Hester, F Issa TRANSPLANT INTERNATIONAL 32, 280-280, 2019 | | 2019 |
